UC148
6-羟基氯唑沙宗
≥98% (HPLC), solid, chlorzoxazone metabolite
别名:
5-Chloro-6-hydroxybenzoxazone, 5-氯-6-羟基-2(3H)-苯并噁唑酮
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C7H4ClNO3
化学文摘社编号:
分子量:
185.56
UNSPSC Code:
12161501
PubChem Substance ID:
NACRES:
NA.77
MDL number:
产品名称
6-羟基氯唑沙宗, ≥98% (HPLC)
SMILES string
Oc1cc2OC(=O)Nc2cc1Cl
InChI key
AGLXDWOTVQZHIQ-UHFFFAOYSA-N
InChI
1S/C7H4ClNO3/c8-3-1-4-6(2-5(3)10)12-7(11)9-4/h1-2,10H,(H,9,11)
assay
≥98% (HPLC)
form
solid
color
white to pink
solubility
methanol: soluble
storage temp.
2-8°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
6-羟基氯唑沙宗已用于基于 HPLC 的氯唑沙宗代谢分析 。
6-羟基氯唑沙宗已被用作：作为参考标准品，在重组人酶筛选中监测底物消耗或通过细胞色素 P450 家族 2 亚家族 E 成员 1 (CYP2E1) 所形成的 6-羟基氯唑沙宗。6-羟基氯唑沙宗已被用于基于高效液相色谱 (HPLC) 的氯唑沙宗代谢测定。
氯唑沙宗的 CYP2E1 & 1A2 代谢物。
Biochem/physiol Actions
6-羟基氯唑沙宗是一种新型氯唑沙宗代谢物。它是由细胞色素 P450 家族 2 亚家族 E 成员 1 (CYP2E1) 酶将氯唑沙宗羟基化形成的。确定 6-羟基氯唑沙宗的形成和清除被用作表征 CYP2E1 代谢活性的一种可靠标记。
Packaging
无底玻璃瓶。内含物装在插入的融合锥内。
Preparation Note
6-羟基氯唑沙宗可溶于甲醇。
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
C B Eap et al.
Journal of chromatography. B, Biomedical sciences and applications, 705(1), 139-144 (1998-03-14)
A gas chromatographic-mass spectrometric method is presented which allows the determination of chlorzoxazone and 6-hydroxychlorzoxazone after derivatization with the reagent N-tert.-butyldimethylsilyl-N-methyltrifluoroacetamide. No interference was observed from endogenous compounds following the extraction of plasma samples from six different human subjects. The
Drug Metabolism in Chronic Kidney Disease
Chronic Renal Disease, 1035-1051 (2020)
In vitro CYP/FMO Reaction Phenotyping
Optimization in Drug Discovery: In Vitro Methods, 137-169 (2014)
Anna M Lee et al.
European journal of pharmacology, 552(1-3), 151-158 (2006-10-20)
Cytochrome P450 2E1 (CYP2E1) is expressed in the brain and liver, and can metabolize clinical drugs and activate toxins. The effect of phenobarbital on hepatic and brain CYP2E1 is unclear. We investigated the effect of chronic phenobarbital treatment on in
Choong Y Ahn et al.
Drug metabolism and disposition: the biological fate of chemicals, 36(7), 1233-1241 (2008-04-02)
Protein expression of the hepatic CYP2E1 has been reported to be increased in diabetic rats. This enzyme is the primary metabolizer of chlorzoxazone (CZX) to 6-hydroxychlorzoxazone (OH-CZX). Although patients with liver cirrhosis have a higher prevalence of diabetes mellitus, there
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持